Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Michael J. Wehle is active.

Publication


Featured researches published by Michael J. Wehle.


The Journal of Urology | 2000

EFFICACY AND SAFETY OF VALRUBICIN FOR THE TREATMENT OF BACILLUS CALMETTE-GUERIN REFRACTORY CARCINOMA IN SITU OF THE BLADDER

Gary D. Steinberg; Robert Bahnson; Stanley A. Brosman; Richard P. Middleton; Zev Wajsman; Michael J. Wehle

Purpose: We assess the efficacy and safety of intravesical valrubicin for the treatment of carcinoma in situ in patients with failure or recurrence after bacillus Calmette-Guerin (BCG) and who othe...


Radiotherapy and Oncology | 2009

Late toxicity after postprostatectomy salvage radiation therapy

Jennifer L. Peterson; Steven J. Buskirk; Michael G. Heckman; Julia E. Crook; Stephen J. Ko; Michael J. Wehle; Todd C. Igel; Karin Prussak; Thomas M. Pisansky

PURPOSEnTo evaluate late toxicity in patients who received salvage external beam radiotherapy (EBRT) for a detectable prostate-specific antigen (PSA) level after radical prostatectomy (RP).nnnMETHODSnA cohort of 308 consecutive patients underwent salvage EBRT from July 1987 through June 2003 for a detectable PSA level after RP. All were treated with high-energy photons (6-20 MV) to a median dose of 64.8 Gy (range: 54.0-72.4 Gy) in 1.8- to 2.0-Gy fractions.nnnRESULTSnMedian follow-up from the completion of EBRT was 60 months (range: 1 day-174 months). Late toxicity occurring more than 90 days after EBRT completion was identified in 41 patients (13%). Twelve patients (3.9%) had grade 2 urethral strictures and were treated with urethral dilation, 3 patients had grade 3 cystitis, and 1 had a grade 4 rectal complication. These numbers correspond to an estimated 0.7% (95% confidence interval, 0.0-1.6%) of patients experiencing a grade 3 or 4 complication by 5 years after the start of EBRT.nnnCONCLUSIONSnSalvage EBRT for a detectable PSA level after RP is the only curative treatment in this setting. This treatment can be administered in a manner that results in a low likelihood of late complications.


Urology | 2011

Robotic-assisted Bladder Diverticulectomy: Tips and Tricks

David D. Thiel; Paul R. Young; Michael J. Wehle; Gregory A. Broderick; Steven P. Petrou; Todd C. Igel

INTRODUCTIONnThe da Vinci Surgical System has become extremely popular in the field of urology for procedures requiring complex reconstructive maneuvers, such as radical prostatectomy and pyeloplasty. A natural extension of these procedures is the use of the da Vinci system for complex urinary tract reconstruction deep in the pelvis, such as bladder diverticulectomy.nnnTECHNICAL CONSIDERATIONSnIn our report and accompanying Video, we have demonstrated some technical tips and tricks with regard to patient selection, preoperative imaging, patient positioning, port placement, intraoperative diverticulum recognition/excision, and cystotomy repair that the surgeon might find beneficial for successful completion of robotic-assisted bladder diverticulectomy.nnnCONCLUSIONSnThe tips and tricks we have presented might aid in the successful completion of robotic bladder diverticulectomy.


Archive | 2016

Surgical Techniques in Urology Robotic-assisted Bladder Diverticulectomy: Tips and Tricks

David D. Thiel; Paul R. Young; Michael J. Wehle; Gregory A. Broderick; Steven P. Petrou; Todd C. Igel


Clinical Radiation Oncology (Fourth Edition) | 2016

Chapter 56 – Kidney and Ureteral Carcinoma

William W. Wong; Jennifer L. Peterson; Winston Tan; Michael G. Haddock; Alexander S. Parker; Michael J. Wehle; Ryan Hutchinson


The Journal of Urology | 2011

477 CHANGES IN AUA SCORE FROM BASELINE TO ONE YEAR: COMPARISON OF AGE-MATCHED MEN UNDERGOING CRYOTHERAPY, RADICAL PROSTATECTOMY AND EXTERNAL BEAM RADIATION FOR NEWLY DIAGNOSED PROSTATE CANCER

Alexander S. Parker; Adam J. Clemens; Andrea Tavlarides; Nancy N. Diehl; Michael G. Heckman; Michael J. Wehle


Urology | 2007

Klinik veya Ürodinamik Parametreler Post-Radikal Prostatektomi İnkontinansda Yapay Üriner Sfinkter Sonuçlarını Önceden Bildirebilir mi?

David D. Thiel; Paul R. Young; Gregory A. Broderick; Michael G. Heckman; Michael J. Wehle; Todd C. Igel; ve Steven P. Petrou


The Journal of Urology | 2007

1256: Lower Tumor Expression Levels of the Transforming Growth Factor Beta Receptor Type II Protein are Associated with a Less Aggressive Tumor Phenotype and Improved Survival Among Patients with Clear Cell Renal Cell Carcinoma

Alexander S. Parker; Christine M. Lohse; Kevin J. Wu; John A. Copland; Michael J. Wehle; John C. Cheville


The Journal of Urology | 2006

1366: Do Clinical and Urodynamic Parameters Predict Artificial Urinary Sphincter Outcome for Post-Radical Prostatectomy Incontinence? A 10 Year Experience

David D. Thiel; Paul R. Young; Steven P. Petrou; Gregory A. Broderick; Michael J. Wehle; Todd C. Igel


The Journal of Urology | 2005

472: Predictors of Biochemical Relapse Following Salvage Radiation Therapy for Recurrent Prostate Cancer

Alexander S. Parker; Steven J. Buskirk; Michael G. Heckman; Tim Pisansky; Karen A. Prussak; Michael J. Wehle; Robert G. Ferrigni; Steven E. Schild; Robert P. Myers

Collaboration


Dive into the Michael J. Wehle's collaboration.

Researchain Logo
Decentralizing Knowledge